We’re Horizon Therapeutics, a global biotechnology company driven by a simple idea: We believe that science and compassion must work together to transform lives.
Our pipeline is purposeful: We apply scientific expertise and courage to bring clinically meaningful therapies to patients.
We’re driven by a clear purpose: to improve patients’ lives. And the clearest expression of that purpose is the portfolio of medicines we offer to treat rare, autoimmune and severe inflammatory diseases.
05/23/2023 Horizon Therapeutics plc Announces Presentation of Data that Advances the Understanding of Rheumatic Diseases at the 2023 EULAR European Congress of Rheumatology 05/16/2023 Horizon Therapeutics plc Responds to U.S. Federal Trade Commission (FTC) Action to Block Acquisition by Amgen